Literature DB >> 29019364

A serving of blueberry (V. corymbosum) acutely improves peripheral arterial dysfunction in young smokers and non-smokers: two randomized, controlled, crossover pilot studies.

Cristian Del Bo'1, Valeria Deon, Jonica Campolo, Claudia Lanti, Marina Parolini, Marisa Porrini, Dorothy Klimis-Zacas, Patrizia Riso.   

Abstract

Several studies have documented the important role of polyphenol-rich foods in the modulation of vascular remodelling and function. This study aimed to evaluate the capacity of a single portion of blueberry (V. corymbosum) to acutely improve peripheral arterial dysfunction in a group of young volunteers. Twenty-four healthy males (12 non-smokers and 12 smokers) were recruited for two different randomized, controlled, crossover pilot acute studies. In the first study, non-smokers were exposed to a control treatment (C; 300 mL of water with sugar) and a blueberry treatment (BB; 300 g of blueberry). In the second study, smokers underwent 3 different protocols: (1) - smoking treatment (S); (2) - control treatment (CS; 300 mL of water with sugar + smoking); (3) - blueberry treatment (BS; 300 g of blueberry + smoking). Each treatment (1 day long) was separated by a one week washout period. Blood pressure, peripheral arterial function (reactive hyperemia index, RHI, a marker of endothelial function) and arterial stiffness (digital augmentation index, dAix and dAix normalized by considering a heart rate of 75 bpm, dAix@75) were measured before and after each treatment. In the first study, the consumption of blueberry and control treatment acutely increased peripheral arterial function in the group of non-smokers. The improvement in RHI was higher and significantly different after blueberry treatment compared to the control treatment (54.8 ± 8.4% BB vs. 28.2 ± 8.3% C; p = 0.01). No effects were observed for markers of arterial stiffness, blood pressure and heart rate. Acute cigarette smoke significantly increased blood pressure and heart rate, while no significant effect was registered in peripheral arterial function and stiffness. The intake of blueberry and control treatment before a cigarette did not counteract the increase in blood pressure and heart rate, while it significantly improved peripheral arterial function. In particular, a significant increase was observed following BS (35.2 ± 7.5% RHI; p = 0.02) and CS treatments (34.6 ± 11.9% RHI; p = 0.02) when compared to only smoking treatment. No difference between BS and CS was detected. In conclusion, the intake of blueberry and control treatments acutely improved peripheral arterial dysfunction both in smoker and in non-smoker subjects. Further studies should be performed to confirm the results obtained and reveal the potential mechanisms of blueberry in the improvement of endothelial function.

Entities:  

Mesh:

Year:  2017        PMID: 29019364     DOI: 10.1039/c7fo00861a

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  9 in total

1.  Effects of Blueberry Consumption on Cardiovascular Health in Healthy Adults: A Cross-Over Randomised Controlled Trial.

Authors:  Yueyue Wang; Jose Lara Gallegos; Crystal Haskell-Ramsay; John K Lodge
Journal:  Nutrients       Date:  2022-06-21       Impact factor: 6.706

Review 2.  The Role of Berry Consumption on Blood Pressure Regulation and Hypertension: An Overview of the Clinical Evidence.

Authors:  Stefano Vendrame; Tolu Esther Adekeye; Dorothy Klimis-Zacas
Journal:  Nutrients       Date:  2022-06-29       Impact factor: 6.706

3.  Dietary Blueberry Ameliorates Vascular Complications in Diabetic Mice Possibly through NOX4 and Modulates Composition and Functional Diversity of Gut Microbes.

Authors:  Chrissa Petersen; Divya Bharat; Umesh D Wankhade; Ji-Seok Kim; Brett Ronald Cutler; Christopher Denetso; Samira Gholami; Samantha Nelson; Jessica Bigley; Aspen Johnson; Sree V Chintapalli; Brian D Piccolo; Adhini Kuppuswamy Satheesh Babu; Henry A Paz; Kartik Shankar; J David Symons; Pon Velayutham Anandh Babu
Journal:  Mol Nutr Food Res       Date:  2022-02-25       Impact factor: 6.575

4.  A mix of chlorogenic and caffeic acid reduces C/EBPß and PPAR-γ1 levels and counteracts lipid accumulation in macrophages.

Authors:  Mirko Marino; Cristian Del Bo; Massimiliano Tucci; Samuele Venturi; Giacomo Mantegazza; Valentina Taverniti; Peter Møller; Patrizia Riso; Marisa Porrini
Journal:  Eur J Nutr       Date:  2021-10-26       Impact factor: 5.614

Review 5.  Dietary Polyphenols Targeting Arterial Stiffness: Interplay of Contributing Mechanisms and Gut Microbiome-Related Metabolism.

Authors:  Tess De Bruyne; Bieke Steenput; Lynn Roth; Guido R Y De Meyer; Claudia Nunes Dos Santos; Kateřina Valentová; Maija Dambrova; Nina Hermans
Journal:  Nutrients       Date:  2019-03-08       Impact factor: 5.717

6.  Modulation of Adhesion Process, E-Selectin and VEGF Production by Anthocyanins and Their Metabolites in an in vitro Model of Atherosclerosis.

Authors:  Mirko Marino; Cristian Del Bo'; Massimiliano Tucci; Dorothy Klimis-Zacas; Patrizia Riso; Marisa Porrini
Journal:  Nutrients       Date:  2020-02-28       Impact factor: 5.717

7.  Blueberry anthocyanin intake attenuates the postprandial cardiometabolic effect of an energy-dense food challenge: Results from a double blind, randomized controlled trial in metabolic syndrome participants.

Authors:  Peter J Curtis; Lindsey Berends; Vera van der Velpen; Amy Jennings; Laura Haag; Preeti Chandra; Colin D Kay; Eric B Rimm; Aedín Cassidy
Journal:  Clin Nutr       Date:  2021-11-27       Impact factor: 7.324

Review 8.  Plant-Based Foods and Vascular Function: A Systematic Review of Dietary Intervention Trials in Older Subjects and Hypothesized Mechanisms of Action.

Authors:  Massimiliano Tucci; Mirko Marino; Daniela Martini; Marisa Porrini; Patrizia Riso; Cristian Del Bo'
Journal:  Nutrients       Date:  2022-06-24       Impact factor: 6.706

Review 9.  Molecular Mechanism and Health Role of Functional Ingredients in Blueberry for Chronic Disease in Human Beings.

Authors:  Luyao Ma; Zhenghai Sun; Yawen Zeng; Mingcan Luo; Jiazhen Yang
Journal:  Int J Mol Sci       Date:  2018-09-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.